Molecular Pharmacology (USA), Ltd.

Molecular Pharmacology (USA), Ltd.

MLPH - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$643.71K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Molecular Pharmacology (USA), Ltd.Molecular Pharmacology (USA), Ltd.0-0%-1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$643,711.00
Enterprise Value$-1,433,516.00
Earnings per Share$0
Beta0.17
Outstanding Shares19,991,074

Return

Return on Equity0.32%ROE
Return on Assets-75.98%
Return on Invested Capital0.32%

Valuation & Multiples

P/E Ratio-P/E Ratio
PEG-PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.03Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT213.32
Enterprise Value to Net Income213
Total Debt to Enterprise1.45
Debt to Equity0.99Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About AI Energy Inc

CEO: Jeffrey David Edwards

AI Energy Inc., a development stage company, focuses on discovery and development of analgesic and anti-inflammatory products based on the proprietary MPL-TL (tripeptofen) compound. The company was formerly known as Molecular Pharmacolog...